Analyst Coverage Initiated: NUVB rating Buy by H.C. Wainwright
Price Target: $14
Report Date: 05-04-2022
Symbol: NUVB - Nuvation Bio Inc.
Sector: Financial Services
Industry: Biotechnology
Analyst Coverage Initiated: NUVB rating Buy by H.C. Wainwright
Price Target: $14
Nuvation Bio Inc. (NUVB)
357 Tehama Street
San Francisco, CA 10036
Phone: 415-966-0807
Website: http://www.nuvationbio.com
CEO: Mr. Oleg Nodelman
NYSE, New York Stock Exchange
Panacea Acquisition Corp., a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in San Francisco, California.